Related Experiment Video
Updated: Dec 17, 2025

09:33
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.5K
A clinically and genomically annotated nerve sheath tumor biospecimen repository.
Kai Pollard1, Jineta Banerjee2, Xengie Doan2
1Sidney Kimmel Comprehensive Cancer Center and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, USA.
Scientific Data
|June 21, 2020
Summary
Researchers created a valuable resource of patient tumor samples and data for neurofibromatosis type 1 (NF1) nerve sheath tumors. This collection aids the development of new therapies for these challenging conditions.
Area of Science:
- Oncology
- Genetics
- Genomics
Background:
- Nerve sheath tumors are common in neurofibromatosis type 1 (NF1).
- Malignant NF1 tumors are a leading cause of death, while benign tumors cause significant morbidity.
- A scarcity of human peripheral nerve tumor tissue hinders therapeutic development.
Purpose of the Study:
- To establish a comprehensive resource of NF1 peripheral nerve tumor samples and associated data.
- To facilitate biological and preclinical therapeutic research for NF1-associated nerve sheath tumors.
Main Methods:
- Creation of an annotated collection including patient tumor samples, cell lines, and xenografts.
- High-throughput genomic and transcriptomic characterization of collected samples.
- Public release of integrated datasets with clinical annotations.
Main Results:
- Generation of a dataset comprising 55 tumor samples from 23 individuals with NF1.
- Comprehensive genomic and transcriptomic data are now publicly accessible.
- The resource includes detailed clinical annotations for each sample.
Conclusions:
- The developed resource addresses a critical need for NF1 nerve sheath tumor research.
- Publicly available data and samples will accelerate the discovery of new therapeutic strategies.
- This initiative supports future biological and preclinical studies for NF1 patients.

